title: [Topical sirolimus 0.4% formulation for treatment of facial angiofibromas].
authors.forename: I
authors.initials: I
authors.lastname: Cuevas Asencio
authors.forename: R
authors.initials: R
authors.lastname: Albornoz López
authors.forename: R
authors.initials: R
authors.lastname: Salido Vallejo
authors.forename: M
authors.initials: M
authors.lastname: Reyes Malia
mesh_terms: D000287:Administration, Topical; D018322:Angiofibroma / Q000188:drug therapy*; D002626:Chemistry, Pharmaceutical; D002675:Child, Preschool; D005153:Facial Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D020123:Sirolimus / Q000008:administration & dosage / Q000627:therapeutic use*; D014402:Tuberous Sclerosis / Q000150:complications
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus